SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-20-000586
Filing Date
2020-06-16
Accepted
2020-06-16 18:27:45
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 vaxcyte_fm4ajun1520.html 4/A  
1 vaxcyte_fm4ajun1520.xml 4/A 5160
  Complete submission text file 0000905718-20-000586.txt   6572
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39323 | Film No.: 20967594

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)